Home
>
National Drug Code (NDC)
>
Docetaxel
Docetaxel - 0955-1021-04 - (Docetaxel)
Drug Information of Docetaxel
| Product NDC: | 0955-1021 |
| Proprietary Name: | Docetaxel |
| Non Proprietary Name: | Docetaxel |
| Active Ingredient(s): | 80 mg/4mL & nbsp; Docetaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Docetaxel
| Product NDC: | 0955-1021 |
| Labeler Name: | Winthrop U.S. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020449 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101021 |
Package Information of Docetaxel
| Package NDC: | 0955-1021-04 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (0955-1021-04) > 4 mL in 1 VIAL, GLASS |
NDC Information of Docetaxel
| NDC Code | 0955-1021-04 |
| Proprietary Name | Docetaxel |
| Package Description | 1 VIAL, GLASS in 1 CARTON (0955-1021-04) > 4 mL in 1 VIAL, GLASS |
| Product NDC | 0955-1021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Docetaxel |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101021 |
| Marketing Category Name | NDA |
| Labeler Name | Winthrop U.S. |
| Substance Name | DOCETAXEL |
| Strength Number | 80 |
| Strength Unit | mg/4mL |
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
